Adios 2003: A Top Ten List
Executive Summary
In Vivo closes out 2003 with a round-up of the top ten stories in the medical industry, including: Medicare drug coverage, the battle in drug-eluting stents, cut-price drugs imported from Canada, the financing climate in medical devices and biotechnology, the triumph of large molecules, Merck's Phase III failures, consolidation in orthopedics, and other hotly-discussed issues.